Oncolytics Biotech (ONCY) Price to Sales (2009 - 2020)

Oncolytics Biotech (ONCY) has reported Price to Sales for 7 consecutive years, with 1.4 the latest figure, recorded in Q3 2020.

• On a quarterly basis, Price to Sales rose 73.69% year-over-year to 1.4 in Q3 2020; TTM through Sep 2020 was 0.37, a 95.39% increase from a year earlier, with the FY2020 full-year figure at 3.52, changed N/A from the prior year.
• Price to Sales was 1.4 for Q3 2020 at Oncolytics Biotech, up from 1.39 in the prior quarter.
• Over five years, Price to Sales peaked at 85.09 in Q2 2017 and troughed at 0.81 in Q3 2019.
• A 5-year average of 15.68 and a median of 2.3 in 2018 frame the typical range for Price to Sales.
• The widest YoY moves for Price to Sales: up 224.0% in 2019, down 77.31% in 2019.
• Over 5 years, Price to Sales stood at 64.78 in 2016, then jumped by 31.35% to 85.09 in 2017, then sank by 97.3% to 2.3 in 2018, then jumped by 224.0% to 7.45 in 2019, then tumbled by 81.19% to 1.4 in 2020.
• The last three Price to Sales figures came in at 1.4 (Q3 2020), 1.39 (Q2 2020), and 1.0 (Q1 2020), per Business Quant data.